tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Hypertension D006973 115 associated lipids
Ischemic Attack, Transient D002546 42 associated lipids
Glomerulosclerosis, Focal Segmental D005923 4 associated lipids
Cerebrovascular Disorders D002561 25 associated lipids
Dermatitis D003872 30 associated lipids
Gastrointestinal Diseases D005767 20 associated lipids
Vomiting D014839 21 associated lipids
Hypersensitivity, Immediate D006969 14 associated lipids
Subarachnoid Hemorrhage D013345 17 associated lipids
Pharyngitis D010612 2 associated lipids
Shock D012769 11 associated lipids
Erythema D004890 22 associated lipids
Dermatomycoses D003881 17 associated lipids
Hyperalgesia D006930 42 associated lipids
Spinal Cord Injuries D013119 34 associated lipids
Cholelithiasis D002769 16 associated lipids
Fever D005334 35 associated lipids
Amenorrhea D000568 4 associated lipids
Dermatitis, Seborrheic D012628 10 associated lipids
Thrombocytopenia D013921 15 associated lipids
Hyperlipidemias D006949 73 associated lipids
Shock, Septic D012772 11 associated lipids
Ileal Neoplasms D007078 2 associated lipids
Cough D003371 19 associated lipids
Paraproteinemias D010265 2 associated lipids
Encephalomyelitis, Autoimmune, Experimental D004681 26 associated lipids
Translocation, Genetic D014178 20 associated lipids
Catalepsy D002375 30 associated lipids
Dermatitis, Atopic D003876 19 associated lipids
Ovarian Cysts D010048 4 associated lipids
Precursor Cell Lymphoblastic Leukemia-Lymphoma D054198 10 associated lipids
Cardiomegaly D006332 31 associated lipids
Hypertension, Renal D006977 9 associated lipids
Metaplasia D008679 7 associated lipids
Burkitt Lymphoma D002051 15 associated lipids
Leukemia, T-Cell D015458 23 associated lipids
Tachycardia D013610 7 associated lipids
Cicatrix D002921 9 associated lipids
Neutropenia D009503 15 associated lipids
Peritoneal Neoplasms D010534 16 associated lipids
Arthritis, Juvenile D001171 8 associated lipids
Urticaria D014581 13 associated lipids
Behcet Syndrome D001528 7 associated lipids
Fetal Hypoxia D005311 3 associated lipids
Thrombophlebitis D013924 6 associated lipids
Cardiomyopathy, Hypertrophic D002312 6 associated lipids
HIV Seropositivity D006679 15 associated lipids
Uveitis D014605 14 associated lipids
Enterobacteriaceae Infections D004756 5 associated lipids
Alveolar Bone Loss D016301 10 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Shi J et al. Activity-dependent induction of tonic calcineurin activity mediates a rapid developmental downregulation of NMDA receptor currents. 2000 Neuron pmid:11086987
Chang GJ et al. Experience with the use of sirolimus in liver transplantation--use in patients for whom calcineurin inhibitors are contraindicated. 2000 Liver Transpl. pmid:11084060
Bathgate AJ et al. Pretransplantation tumor necrosis factor-alpha production predicts acute rejection after liver transplantation. 2000 Liver Transpl. pmid:11084058
Guo WH et al. Recipient FK506 pretreatment regimens in rat small bowel transplantation: allograft survival, function, and systemic infection. 2000 J. Pediatr. Surg. pmid:11083432
Soncin F et al. Role of calcium activated kinases and phosphatases in heat shock factor-1 activation. 2000 Int. J. Mol. Med. pmid:11078832
Griffith EC et al. Yeast three-hybrid system for detecting ligand-receptor interactions. 2000 Meth. Enzymol. pmid:11075340
Shimizu K et al. Tacrolimus (FK506) treatment of CD34+ hematopoietic progenitor cells promote the development of dendritic cells that drive CD4+ T cells toward Th2 responses. 2000 J. Leukoc. Biol. pmid:11073101
Dale S and Shaw J Clinical picture. Eosinophilic pustular folliculitis. 2000 Lancet pmid:11072943
Miyamoto S et al. Signal transduction pathways that contribute to increased protein synthesis during T-cell activation. 2000 Biochim. Biophys. Acta pmid:11072066
Bova D et al. Delayed transient neurologic toxicity due to tacrolimus: CT and MRI. 2000 Neuroradiology pmid:11071440
Abramowicz D et al. Immunosuppressive strategies in renal transplantation at the beginning of the third millennium. 2000 Adv. Nephrol. Necker Hosp. pmid:11068631
Hernández G et al. Reduction of severe gingival overgrowth in a kidney transplant patient by replacing cyclosporin A with tacrolimus. 2000 J. Periodontol. pmid:11063397
Dominguez J et al. Conversion to rapamycin immunosuppression in renal transplant recipients: report of an initial experience. 2000 Transplantation pmid:11063349
Chisholm MA et al. Renal transplant patient compliance with free immunosuppressive medications. 2000 Transplantation pmid:11063348
Mack-Shipman LR et al. Reproductive hormones after pancreas transplantation. 2000 Transplantation pmid:11063337
Bandyopadhyay A et al. Calcineurin regulates ryanodine receptor/Ca(2+)-release channels in rat heart. 2000 Biochem. J. pmid:11062058
Kuinose M et al. Calcineurin antagonists inhibit interferon-gamma production by downregulation of interleukin-18 in human mixed lymphocyte reactions. 2000 Acta Med. Okayama pmid:11061569
Gold BG Neuroimmunophilin ligands: evaluation of their therapeutic potential for the treatment of neurological disorders. 2000 Expert Opin Investig Drugs pmid:11060810
Paul C et al. Ascomycins: promising agents for the treatment of inflammatory skin diseases. 2000 Expert Opin Investig Drugs pmid:11060661
Bornhövd EC et al. [Immunosuppressive macrolides and their use in dermatology]. 2000 Hautarzt pmid:11057390
Sakata Y et al. Calcineurin inhibitor attenuates left ventricular hypertrophy, leading to prevention of heart failure in hypertensive rats. 2000 Circulation pmid:11056104
Molkentin JD Calcineurin and beyond: cardiac hypertrophic signaling. 2000 Circ. Res. pmid:11055975
Shitamukai A et al. A positive screening for drugs that specifically inhibit the Ca2+-signaling activity on the basis of the growth promoting effect on a yeast mutant with a peculiar phenotype. 2000 Biosci. Biotechnol. Biochem. pmid:11055400
Ono K et al. Altered interaction of FKBP12.6 with ryanodine receptor as a cause of abnormal Ca(2+) release in heart failure. 2000 Cardiovasc. Res. pmid:11054478
Murayama T and Ogawa Y Selectively suppressed Ca2+-induced Ca2+ release activity of alpha-ryanodine receptor (alpha-RyR) in frog skeletal muscle sarcoplasmic reticulum: potential distinct modes in Ca2+ release between alpha- and beta-RyR. 2001 J. Biol. Chem. pmid:11054412
Weimer R et al. Switch from cyclosporine A to tacrolimus in renal transplant recipients: impact on Th1, Th2, and monokine responses. 2000 Hum. Immunol. pmid:11053632
Bechstein WO Neurotoxicity of calcineurin inhibitors: impact and clinical management. 2000 Transpl. Int. pmid:11052266
Ciancio G et al. Partial venous thrombosis of the pancreatic allografts after simultaneous pancreas-kidney transplantation. 2000 Clin Transplant pmid:11048991
Jiang H et al. Distinct patterns of cytokine gene suppression by the equivalent effective doses of cyclosporine and tacrolimus in rat heart allografts. 2000 Immunobiology pmid:11045663
Miyazawa N et al. Protective effect of FK506 in the reperfusion model after short-term occlusion of middle cerebral artery in the rat: assessment by autoradiography using [125I]PK-11195. 2000 Neurol. Res. pmid:11045029
Yano M et al. Altered stoichiometry of FKBP12.6 versus ryanodine receptor as a cause of abnormal Ca(2+) leak through ryanodine receptor in heart failure. 2000 Circulation pmid:11044432
Kantrow SP et al. Regulation of tumor necrosis factor cytotoxicity by calcineurin. 2000 FEBS Lett. pmid:11042265
Przepiorka D et al. Tacrolimus clearance is age-dependent within the pediatric population. 2000 Bone Marrow Transplant. pmid:11041564
Nakahama H et al. Co-administration of furosemide augments tacrolimus-induced impairment in kidney function in rats. 2000 Ren Fail pmid:11041285
Cronin DC et al. Liver transplantation at the University of Chicago. 1999 Clin Transpl pmid:11038642
Shapiro R et al. Simultaneous pancreas-kidney transplantation at the University of Pittsburgh. 1999 Clin Transpl pmid:11038640
Shiraishi S et al. Post-translational reduction of cell surface expression of insulin receptors by cyclosporin A, FK506 and rapamycin in bovine adrenal chromaffin cells. 2000 Neurosci. Lett. pmid:11036198
Shimoyama M et al. Calcineurin inhibitor attenuates the development and induces the regression of cardiac hypertrophy in rats with salt-sensitive hypertension. 2000 Circulation pmid:11034951
Mayer JM et al. Single doses of FK506 and OKT3 reduce severity in early experimental acute pancreatitis. 2000 Eur J Surg pmid:11034471
van Gelder T et al. Drug interaction between mycophenolate mofetil and tacrolimus detectable within therapeutic mycophenolic acid monitoring in renal transplant patients. 2000 Ther Drug Monit pmid:11034275
Taylor PJ et al. Simultaneous quantification of tacrolimus and sirolimus, in human blood, by high-performance liquid chromatography-tandem mass spectrometry. 2000 Ther Drug Monit pmid:11034268
Davis DL and Soldin SJ Identification of ubiquitin as an immunophilin. 2000 Biochem. Biophys. Res. Commun. pmid:11032725
Toma H [Neurologic disorders in renal transplantation]. 2000 Ryoikibetsu Shokogun Shirizu pmid:11031921
Marsen TA et al. Differential transcriptional regulation of endothelin-1 by immunosuppressants FK506 and cyclosporin A. 2000 Jul-Aug Fundam Clin Pharmacol pmid:11030448
Matsuura M et al. Effect of FTY720, a novel immunosuppressant, on adjuvant-induced arthritis in rats. 2000 Inflamm. Res. pmid:11028757
Hayashi T and Miyamori I [Cyclosporine- and tacrolimus-induced hypertension]. 2000 Nippon Rinsho pmid:11028414
Miyake K et al. [Tacrolimus administration to a patient with cyclosporine-induced encephalopathy after allogeneic bone marrow transplantation]. 2000 Rinsho Ketsueki pmid:11020982
Kaufman DB et al. Simultaneous pancreas-kidney transplantation in the mycophenolate mofetil/tacrolimus era: evolution from induction therapy with bladder drainage to noninduction therapy with enteric drainage. 2000 Surgery pmid:11015108
Bronster DJ et al. Tacrolimus-associated mutism after orthotopic liver transplantation. 2000 Transplantation pmid:11014653
Lorf T et al. The effect of pantoprazole on tacrolimus and cyclosporin A blood concentration in transplant recipients. 2000 Eur. J. Clin. Pharmacol. pmid:11009056